Marc Dunoyer - AstraZeneca
Marc Dunoyer has been appointed Chief Financial Officer at Drug Giant AstraZeneca after less than six months at the company in the role of Executive Vice President, Global Portfolio & Product Strategy.
He joined the firm from GlaxoSmithKline and the choice for this role was, according to CEO Pascal Soriot, down to his “rare blend of financial, business and science experience that will be critical in this role in the coming years as we focus on returning AstraZeneca to growth and achieving scientific leadership.”